| 摘要 |
The present disclosure relates to compounds, which are useful for regulating the expression of apolipoproteiÏ A-I (ApoA-l), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis. |
